A car plowed into pedestrians along the crowded Las Vegas Strip yesterday, killing one and critically injuring at least three, authorities said. Police arrested the driver at the scene.

The car jumped the curb about 5:15 p.m. and drove into people walking in front of the Bally's and Paris hotel-casinos, officials said.

Eleven people were taken to hospitals, county fire spokesman Bob Leinbach said. One person was pronounced dead at University Medical Center, a hospital spokeswoman said. Seven other people, all adults, were being treated at the hospital. Their conditions were not available.

The car's driver, who was not identified, was injured, police said.

Man convicted of funneling money

Abad Elfgeeh, a Yemeni immigrant ice-cream shop owner, was found guilty yesterday of illegally funneling $21.9 million overseas in a case stemming from a major terrorism investigation.

Elfgeeh, 50, was accused of transmitting money around the world without a license from bank accounts linked to his tiny storefront in Brooklyn. He was not charged with any terrorism-related crime although prosecutors said his business was used by a Yemeni cleric convicted earlier this year of a scheme to fund al-Qaida and the Palestinian militant group Hamas.

Elfgeeh could face 15 years in prison.

Domestic-partner benefits granted

The mayor of Salt Lake City signed an executive order yesterday granting domestic-partner benefits to city workers, a decision likely to be challenged, if not in the courts then in the Legislature.

"This is an important step toward recognizing the needs and equality of all city employees," Mayor Rocky Anderson said.

Breast-implant maker gets sales OK

The Food and Drug Administration (FDA) yesterday told a second manufacturer it can resume unrestricted sales of its controversial silicone-gel implants for breast enlargement and reconstruction if it meets certain unspecified conditions.

The agency said it had sent an "approvable" letter to Inamed as an intermediate step in its review of an application to resume general sale of the implants. In July, the agency sent a similar letter to Mentor.

Neither the FDA nor the companies disclosed the conditions. Because of concerns that the implants might cause a range of life-threatening autoimmune diseases, the FDA limited their use in 1992 to women who have had mastectomies.

About 250,000 U.S. women a year receive breast implants, but since the 1992 restrictions, most have been filled with salt water. The silicone-gel implants are generally regarded as having a more natural look and feel and are expected to become the implant of choice if the agency allows general sales. They are widely used abroad.

Compiled by The Associated Press and The Washington Post